Condition
Cancer Treatment-induced Thrombocytopenia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Cancer Treatment-induced Thrombocytopenia clinical trials that are recruiting, in China. By phase: Phase 2 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Umbilical cord blood therapy for cancer treatment–related low platelets
This trial will try an intravenous umbilical cord blood infusion to see if it raises platelet counts in people aged 12–65 with cancer treatment–induced thrombocytopenia.
-
QL0911 to treat chemotherapy-related low platelet counts
This study will try whether QL0911 can raise platelet counts and reduce chemotherapy delays in adults who develop low platelets from cancer treatment.
Related topics
Quick answers
How many Cancer Treatment-induced Thrombocytopenia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.